MRK vs. NVO
Compare and contrast key facts about Merck & Co., Inc. (MRK) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRK or NVO.
Correlation
The correlation between MRK and NVO is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRK vs. NVO - Performance Comparison
Key characteristics
MRK:
-0.19
NVO:
0.15
MRK:
-0.12
NVO:
0.44
MRK:
0.98
NVO:
1.05
MRK:
-0.15
NVO:
0.14
MRK:
-0.33
NVO:
0.35
MRK:
11.98%
NVO:
12.98%
MRK:
21.10%
NVO:
30.53%
MRK:
-68.62%
NVO:
-71.30%
MRK:
-24.05%
NVO:
-29.32%
Fundamentals
MRK:
$253.12B
NVO:
$486.49B
MRK:
$4.78
NVO:
$2.99
MRK:
20.93
NVO:
36.12
MRK:
0.07
NVO:
1.61
MRK:
$63.22B
NVO:
$270.58B
MRK:
$47.97B
NVO:
$229.07B
MRK:
$20.41B
NVO:
$135.97B
Returns By Period
In the year-to-date period, MRK achieves a -6.22% return, which is significantly lower than NVO's 1.09% return. Over the past 10 years, MRK has underperformed NVO with an annualized return of 9.17%, while NVO has yielded a comparatively higher 19.11% annualized return.
MRK
-6.22%
3.91%
-22.12%
-2.96%
5.84%
9.17%
NVO
1.09%
0.79%
-26.36%
3.23%
31.11%
19.11%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRK vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRK vs. NVO - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 3.14%, more than NVO's 1.40% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% | 3.46% |
NVO Novo Nordisk A/S | 1.40% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% | 1.72% |
Drawdowns
MRK vs. NVO - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.62%, roughly equal to the maximum NVO drawdown of -71.30%. Use the drawdown chart below to compare losses from any high point for MRK and NVO. For additional features, visit the drawdowns tool.
Volatility
MRK vs. NVO - Volatility Comparison
The current volatility for Merck & Co., Inc. (MRK) is 6.51%, while Novo Nordisk A/S (NVO) has a volatility of 7.70%. This indicates that MRK experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MRK vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities